NO20022157D0 - Fremgangsmåte for behandling av medikamentavhengighet - Google Patents

Fremgangsmåte for behandling av medikamentavhengighet

Info

Publication number
NO20022157D0
NO20022157D0 NO20022157A NO20022157A NO20022157D0 NO 20022157 D0 NO20022157 D0 NO 20022157D0 NO 20022157 A NO20022157 A NO 20022157A NO 20022157 A NO20022157 A NO 20022157A NO 20022157 D0 NO20022157 D0 NO 20022157D0
Authority
NO
Norway
Prior art keywords
drug dependence
treating drug
treating
dependence
drug
Prior art date
Application number
NO20022157A
Other languages
English (en)
Other versions
NO20022157L (no
Inventor
Albert Shulman
Original Assignee
Albert Shulman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9926218.0A external-priority patent/GB9926218D0/en
Priority claimed from GBGB9929595.8A external-priority patent/GB9929595D0/en
Application filed by Albert Shulman filed Critical Albert Shulman
Publication of NO20022157D0 publication Critical patent/NO20022157D0/no
Publication of NO20022157L publication Critical patent/NO20022157L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20022157A 1999-11-06 2002-05-06 Fremgangsmåte for behandling av medikamentavhengighet NO20022157L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9926218.0A GB9926218D0 (en) 1999-11-06 1999-11-06 Composition and method for the treatment of drug abuse
GBGB9929595.8A GB9929595D0 (en) 1999-12-16 1999-12-16 New composition and method for the treatment of drug abuse
PCT/AU2000/001367 WO2001034161A1 (en) 1999-11-06 2000-11-06 A method of treating substance addiction

Publications (2)

Publication Number Publication Date
NO20022157D0 true NO20022157D0 (no) 2002-05-06
NO20022157L NO20022157L (no) 2002-07-04

Family

ID=26316056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022157A NO20022157L (no) 1999-11-06 2002-05-06 Fremgangsmåte for behandling av medikamentavhengighet

Country Status (9)

Country Link
EP (1) EP1242093A1 (no)
JP (1) JP2004508274A (no)
KR (1) KR20020063180A (no)
CN (1) CN1402638A (no)
AU (1) AU1256501A (no)
CA (1) CA2390101A1 (no)
NO (1) NO20022157L (no)
NZ (1) NZ518992A (no)
WO (1) WO2001034161A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050043345A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
DK2437744T3 (en) 2009-06-03 2015-07-27 Univ Marquette The modulation of the KCNQ potassium channel activity for the treatment of psychiatric disorders and symptoms thereof
US20240139135A1 (en) * 2019-10-11 2024-05-02 The Trustees Of Indiana University Pregabalin for treatment of opioid use disorder

Also Published As

Publication number Publication date
KR20020063180A (ko) 2002-08-01
NO20022157L (no) 2002-07-04
CA2390101A1 (en) 2001-05-17
NZ518992A (en) 2004-02-27
AU1256501A (en) 2001-06-06
EP1242093A1 (en) 2002-09-25
WO2001034161A1 (en) 2001-05-17
JP2004508274A (ja) 2004-03-18
CN1402638A (zh) 2003-03-12

Similar Documents

Publication Publication Date Title
NO20030241D0 (no) Fremgangsmåte for behandling av multiple brönnintervaller
NO20014960L (no) Nye fremgangsmåter for behandling
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ID30339A (id) Metode pengobatan baru
NO20010117L (no) Fremgangsmåte for behandling av sövnlöshet
NO20015469D0 (no) Fremgangsmåte for behandling av petroleumsyrer
NO20014222L (no) Fremgangsmåte for behandling av COPD
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20020784L (no) Medikament for behandling av brudd
NO20014812L (no) Fremgangsmate for tilveiebringelse av kosmetisk/medisinsk terapi
NO20014848L (no) Fremgangsmåte for anvendelse av emamectin for behandling av fiskeparasitter
PT1228056E (pt) Metodo de preparacao de citaloprame
NO20022157D0 (no) Fremgangsmåte for behandling av medikamentavhengighet
NO20015162D0 (no) Fremgangsmåte for behandling av nevrodegenerering
NO20006383D0 (no) Fremgangsmåte for behandling
NO20014026D0 (no) Krampestillende derivater til behandling av betydelig skjelving
NO20022990L (no) Fremgangsmåte og sammensetning for behandling av smerte
NO20022984L (no) Forbindelse og fremgangsmåte for behandling av smerte
UA33595A (uk) Спосіб лікування простої шизофренії
UA33583A (uk) Спосіб терапії простої шизофренії
UA34051A (uk) Спосіб лікування аскоферозу бджіл
UA33970A (uk) Спосіб лікування періодонтиту

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application